|
LATS1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.94449950269893E-10 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.06290000023712E-07 |
| Normal-vs-Stage2 |
8.60440000027829E-07 |
| Normal-vs-Stage3 |
3.92410004490529E-09 |
| Normal-vs-Stage4 |
3.55559999998256E-07 |
| Stage1-vs-Stage2 |
3.256200E-01 |
| Stage1-vs-Stage3 |
1.918990E-01 |
| Stage1-vs-Stage4 |
3.926200E-01 |
| Stage2-vs-Stage3 |
9.734800E-01 |
| Stage2-vs-Stage4 |
8.054800E-01 |
| Stage3-vs-Stage4 |
7.999000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.60530000193182E-09 |
| Normal-vs-AfricanAmerican |
1.080150E-02 |
| Normal-vs-Asian |
1.75510000000045E-06 |
| Caucasian-vs-AfricanAmerican |
2.269200E-01 |
| Caucasian-vs-Asian |
7.103400E-01 |
| AfricanAmerican-vs-Asian |
1.824200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.11940456903881E-11 |
| Normal-vs-Female |
4.56199999998574E-08 |
| Male-vs-Female |
3.777800E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.93940000003945E-06 |
| Normal-vs-Age(41-60Yrs) |
1.419300010852E-09 |
| Normal-vs-Age(61-80Yrs) |
1.98259999528716E-08 |
| Normal-vs-Age(81-100Yrs) |
8.019100E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.228010E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.740980E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.257200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.374200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.341000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.464600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.309400E-01 |
| Classical-VS-Follicular |
4.096300E-03 |
| Classical-VS-Other |
1.226360E-01 |
| Classical-VS-Normal |
3.34550000036238E-07 |
| Tall-VS-Follicular |
5.241400E-01 |
| Tall-VS-Other |
2.953600E-01 |
| Tall-VS-Normal |
1.55645999999621E-05 |
| Follicular-VS-Other |
5.516800E-01 |
| Follicular-VS-Normal |
7.09200032034119E-10 |
| Other-VS-Normal |
7.393000E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.59079971417952E-10 |
| Normal-vs-N1 |
1.33069999996849E-06 |
| N0-vs-N1 |
7.942200E-01 |
|
|
